{"id":7929,"date":"2023-11-01T06:12:54","date_gmt":"2023-11-01T06:12:54","guid":{"rendered":"https:\/\/infundpros.com\/markets\/gsk-reports-earnings-wednesday-heres-what-to-expect\/"},"modified":"2023-11-01T06:12:55","modified_gmt":"2023-11-01T06:12:55","slug":"gsk-reports-earnings-wednesday-heres-what-to-expect","status":"publish","type":"post","link":"https:\/\/infundpros.com\/?p=7929","title":{"rendered":"GSK Reports Earnings Wednesday. Here’s What to Expect."},"content":{"rendered":"
\n
<\/p>\n

<\/p>\n

<\/p>\n<\/figure><\/div>\n

The U.K. drugmaker
\n GSK
\n reports earnings Wednesday, in the midst of what\u2019s been a perilous season for pharmaceutical results.<\/p>\n

Shares of
\n Bristol Myers Squibb
\n (BMY),
\n AbbVie
\n (ABBV),
\n Sanofi
\n (SNY), and
\n Amgen
\n (AMGN) all fell following their financial results this earnings season. On Wednesday, it\u2019s
\n GSK\u2019s<\/span>
\n (GSK) turn to face the market reaction after the company reports earnings.<\/p>\n

\n

GSK\u2019s American depositary receipt has outperformed many of its pharma peers so far this year. Putting aside
\n Eli Lilly
\n (LLY) and
\n Novo Nordisk
\n (NVO)\u2014whose new anti-obesity medicines have driven dramatic spikes in their share prices\u2014GSK is among the best performers of the group. The GSK American depositary receipt is up roughly 1% so far this year, while the S&P 500 Pharmaceuticals industry index has fallen 7%.<\/p>\n

Analysts expect GSK to report earnings of \u00a30.46 per share for the quarter on sales of \u00a37.7 billion ($9.4 billion) on Wednesday morning, according to FactSet.<\/p>\n

GSK will for the first time report sales of Arexvy, its new respiratory syncytial virus vaccine that launched this fall. The company expects the drug to grow into a megablockbuster. It competes with a similar shot from
\n Pfizer,<\/span>
\n which also launched this year.<\/p>\n

Pfizer said Tuesday it had sold $375 million worth of its RSV vaccine, Abrysvo, during the third quarter. Reuters reported Monday that two thirds of the RSV shots administered in the U.S. this season were GSK\u2019s Arexvy.<\/p>\n

In late October, GSK said it would seek expanded regulatory approval for Arexvy for adults aged 50 to 59, based on data from a new Phase 3 study. The shot is currently approved for adults aged 60 and above.<\/p>\n

GSK\u2019s American depositary receipt trades at 9.3 times earnings expected over the next 12 months, below its 5-year average of 12.7 times earnings.<\/p>\n

Write to Josh Nathan-Kazis at josh.nathan-kazis@barrons.com<\/p>\n<\/p><\/div>\n<\/div>\n

Read the full article here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

The U.K. drugmaker GSK reports earnings Wednesday, in the midst of what\u2019s been a perilous season for pharmaceutical results. Shares of Bristol…<\/p>\n","protected":false},"author":1,"featured_media":7930,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[],"class_list":{"0":"post-7929","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-markets"},"yoast_head":"\nGSK Reports Earnings Wednesday. Here's What to Expect. | inFundPros<\/title>\n<meta name=\"description\" content=\"The U.K. drugmaker GSK reports earnings Wednesday, in the midst of what\u2019s been a perilous season for pharmaceutical results. Shares of Bristol Myers\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/infundpros.com\/?p=7929\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GSK Reports Earnings Wednesday. Here's What to Expect. | inFundPros\" \/>\n<meta property=\"og:description\" content=\"The U.K. drugmaker GSK reports earnings Wednesday, in the midst of what\u2019s been a perilous season for pharmaceutical results. Shares of Bristol Myers\" \/>\n<meta property=\"og:url\" content=\"https:\/\/infundpros.com\/?p=7929\" \/>\n<meta property=\"og:site_name\" content=\"inFundPros\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-01T06:12:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-01T06:12:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/11\/1698819175_social.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"640\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Press Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Press Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/infundpros.com\/?p=7929#article\",\"isPartOf\":{\"@id\":\"https:\/\/infundpros.com\/?p=7929\"},\"author\":{\"name\":\"Press Room\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff\"},\"headline\":\"GSK Reports Earnings Wednesday. Here’s What to Expect.\",\"datePublished\":\"2023-11-01T06:12:54+00:00\",\"dateModified\":\"2023-11-01T06:12:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/infundpros.com\/?p=7929\"},\"wordCount\":312,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/infundpros.com\/#organization\"},\"articleSection\":[\"Markets\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/infundpros.com\/?p=7929#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/infundpros.com\/?p=7929\",\"url\":\"https:\/\/infundpros.com\/?p=7929\",\"name\":\"GSK Reports Earnings Wednesday. Here's What to Expect. | inFundPros\",\"isPartOf\":{\"@id\":\"https:\/\/infundpros.com\/#website\"},\"datePublished\":\"2023-11-01T06:12:54+00:00\",\"dateModified\":\"2023-11-01T06:12:55+00:00\",\"description\":\"The U.K. drugmaker GSK reports earnings Wednesday, in the midst of what\u2019s been a perilous season for pharmaceutical results. Shares of Bristol Myers\",\"breadcrumb\":{\"@id\":\"https:\/\/infundpros.com\/?p=7929#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/infundpros.com\/?p=7929\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/infundpros.com\/?p=7929#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/infundpros.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GSK Reports Earnings Wednesday. Here’s What to Expect.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/infundpros.com\/#website\",\"url\":\"https:\/\/infundpros.com\/\",\"name\":\"Fintech Advance\",\"description\":\"Latest Finance and Tech News and Updates\",\"publisher\":{\"@id\":\"https:\/\/infundpros.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/infundpros.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/infundpros.com\/#organization\",\"name\":\"Fintech Advance\",\"url\":\"https:\/\/infundpros.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png\",\"contentUrl\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png\",\"width\":409,\"height\":70,\"caption\":\"Fintech Advance\"},\"image\":{\"@id\":\"https:\/\/infundpros.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff\",\"name\":\"Press Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png\",\"contentUrl\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png\",\"caption\":\"Press Room\"},\"sameAs\":[\"https:\/\/infundpros.com\"],\"url\":\"https:\/\/infundpros.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GSK Reports Earnings Wednesday. Here's What to Expect. | inFundPros","description":"The U.K. drugmaker GSK reports earnings Wednesday, in the midst of what\u2019s been a perilous season for pharmaceutical results. Shares of Bristol Myers","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/infundpros.com\/?p=7929","og_locale":"en_US","og_type":"article","og_title":"GSK Reports Earnings Wednesday. Here's What to Expect. | inFundPros","og_description":"The U.K. drugmaker GSK reports earnings Wednesday, in the midst of what\u2019s been a perilous season for pharmaceutical results. Shares of Bristol Myers","og_url":"https:\/\/infundpros.com\/?p=7929","og_site_name":"inFundPros","article_published_time":"2023-11-01T06:12:54+00:00","article_modified_time":"2023-11-01T06:12:55+00:00","og_image":[{"width":1280,"height":640,"url":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/11\/1698819175_social.jpeg","type":"image\/jpeg"}],"author":"Press Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Press Room","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/infundpros.com\/?p=7929#article","isPartOf":{"@id":"https:\/\/infundpros.com\/?p=7929"},"author":{"name":"Press Room","@id":"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff"},"headline":"GSK Reports Earnings Wednesday. Here’s What to Expect.","datePublished":"2023-11-01T06:12:54+00:00","dateModified":"2023-11-01T06:12:55+00:00","mainEntityOfPage":{"@id":"https:\/\/infundpros.com\/?p=7929"},"wordCount":312,"commentCount":0,"publisher":{"@id":"https:\/\/infundpros.com\/#organization"},"articleSection":["Markets"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/infundpros.com\/?p=7929#respond"]}]},{"@type":"WebPage","@id":"https:\/\/infundpros.com\/?p=7929","url":"https:\/\/infundpros.com\/?p=7929","name":"GSK Reports Earnings Wednesday. Here's What to Expect. | inFundPros","isPartOf":{"@id":"https:\/\/infundpros.com\/#website"},"datePublished":"2023-11-01T06:12:54+00:00","dateModified":"2023-11-01T06:12:55+00:00","description":"The U.K. drugmaker GSK reports earnings Wednesday, in the midst of what\u2019s been a perilous season for pharmaceutical results. Shares of Bristol Myers","breadcrumb":{"@id":"https:\/\/infundpros.com\/?p=7929#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/infundpros.com\/?p=7929"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/infundpros.com\/?p=7929#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/infundpros.com\/"},{"@type":"ListItem","position":2,"name":"GSK Reports Earnings Wednesday. Here’s What to Expect."}]},{"@type":"WebSite","@id":"https:\/\/infundpros.com\/#website","url":"https:\/\/infundpros.com\/","name":"Fintech Advance","description":"Latest Finance and Tech News and Updates","publisher":{"@id":"https:\/\/infundpros.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/infundpros.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/infundpros.com\/#organization","name":"Fintech Advance","url":"https:\/\/infundpros.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/infundpros.com\/#\/schema\/logo\/image\/","url":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png","contentUrl":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png","width":409,"height":70,"caption":"Fintech Advance"},"image":{"@id":"https:\/\/infundpros.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff","name":"Press Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/infundpros.com\/#\/schema\/person\/image\/","url":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png","contentUrl":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png","caption":"Press Room"},"sameAs":["https:\/\/infundpros.com"],"url":"https:\/\/infundpros.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts\/7929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7929"}],"version-history":[{"count":1,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts\/7929\/revisions"}],"predecessor-version":[{"id":7931,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts\/7929\/revisions\/7931"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/media\/7930"}],"wp:attachment":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7929"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7929"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}